Search

FEMA Floodplains 100 Year Layer Information

Meeting minutes of the Peace Commission meeting held January 19, 2011

Minutes for February 2025 Human rights Commission meeting

Meeting minutes of the Commission on the Status of Women meeting held February 10, 2021

meeting minutes of the Commission for Persons with Disabilities Advisory Board meeting held November 12th, 2015

Meeting Minutes of the Commission for Persons with Disabilities Advisory Board meeting held March 14th, 2013

7/7/2015 License Commission General Hearing minutes

Meeting minutes of the GLBT Commission meeting held November 19th, 2015

Today (August 23, 2021), the U.S. Food and Drug Administration approved the first COVID-19 vaccine. The vaccine has been known as the Pfizer-BioNTech COVID-19 Vaccine, and will now be marketed as Comirnaty (koe-mir’-na-tee), for the prevention of COVID-19 disease in individuals 16 years of age and older. The vaccine also continues to be available under emergency use authorization (EUA), including for individuals 12 through 15 years of age and for the administration of a third dose in certain immunocompromised individuals.

Today (January 31, 2022), the U.S. Food and Drug Administration approved a second COVID-19 vaccine. The vaccine has been known as the Moderna COVID-19 Vaccine; the approved vaccine will be marketed as Spikevax for the prevention of COVID-19 in individuals 18 years of age and older.